Why are Higher CD34+ Cell Doses Associated with Improved Outcomes among Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors – But Not for High-Risk Neuroblastoma?
Saved in:
| Title: | Why are Higher CD34+ Cell Doses Associated with Improved Outcomes among Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors – But Not for High-Risk Neuroblastoma? |
|---|---|
| Authors: | Knight, Tristan E.1,2 (AUTHOR), Broglie, Larisa3,4 (AUTHOR) lbroglie@mcw.edu, Sharma, Akshay5 (AUTHOR), Qayed, Muna6 (AUTHOR), Yanik, Gregory A.7 (AUTHOR) |
| Source: | Pediatric Hematology & Oncology. Feb2025, Vol. 42 Issue 1, p63-67. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 08880018 |
|---|---|
| DOI: | 10.1080/08880018.2024.2420924 |
